BioAtla (BCAB) Debt Ratio (2020 - 2021)
BioAtla (BCAB) posted quarterly Debt Ratio of 0.0 for Q2 2021, up 5.71% quarter-over-quarter from 0.0 in Q1 2021.
BioAtla (BCAB) Debt Ratio (2020 - 2021) Analysis & Trends
BioAtla's Debt Ratio history runs 2 years deep, the most recent figure standing at 0.0 for Q2 2021.
- In Q2 2021, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Jun 2021 stood at 0.0 (changed N/A YoY), while the FY2020 annual figure was 0.0, changed N/A from the prior year.
- Debt Ratio for Q2 2021 stood at 0.0, up from 0.0 in the prior quarter.
- The five-year high for Debt Ratio was 0.0 in Q2 2021, with the low at 0.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.47 |
| 10 | BioAtla | 5.51 Mn | 5.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |